Caribou Biosciences : KOL discussion of CB-010 ANTLER Phase 1 final trial data at ASCO
Market Closed - Nasdaq 04:00:00 2024-05-31 pm EDT 5-day change 1st Jan Change 2.88 USD +1.05% -3.03% -49.74% June 02, 2024 at 07:10 pm EDT June 2, 2024 CB-010 ANTLER Phase 1 trial update and KOL discussion Transformative genome-edited therapies for …